Learn More
Medchemexpress LLC Benzamide, 4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]-2-fluoro-N-(methyl-d3)- | 1443331-82-5 | >99.8% | C21H13D3F4N4O2S | 5 MG

Supplier: Medchemexpress LLC HY70002S5MG
Deutenzalutamide-d3 (Enzalutamide-d3) is a deuterium-labeled variant of Enzalutamide. Enzalutamide is recognized as an androgen receptor (AR) antagonist, demonstrating an IC50 of 36 nM in LNCaP prostate cells. This compound is primarily used for research purposes.
- Deuterium-labeled compound for research applications
- Potent androgen receptor antagonist
- IC50 of 36 nM in LNCaP prostate cells
- High purity with >99.8% by LCMS
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.